Despite significant advancements in prostate cancer detection and monitoring, current screening and diagnostic methods for prostate cancer, such as prostate specific antigen (PSA) blood testing, digital rectal examination (DRE), and biopsies, present several limitations [3]. Here, KLK3 is linked to prostate carcinoma.